These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21512165)

  • 21. Plasma levels of active Von Willebrand factor are increased in patients with first ST-segment elevation myocardial infarction: a multicenter and multiethnic study.
    Rutten B; Maseri A; Cianflone D; Laricchia A; Cristell NA; Durante A; Spartera M; Ancona F; Limite L; Hu D; Li H; Uren NG; de Groot PG; Mannucci PM; Roest M
    Eur Heart J Acute Cardiovasc Care; 2015 Feb; 4(1):64-74. PubMed ID: 24833640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic value of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats, member 13) deficiency in septic shock patients involves interleukin-6 and is not dependent on disseminated intravascular coagulation.
    Peigne V; Azoulay E; Coquet I; Mariotte E; Darmon M; Legendre P; Adoui N; Marfaing-Koka A; Wolf M; Schlemmer B; Veyradier A
    Crit Care; 2013 Nov; 17(6):R273. PubMed ID: 24238574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The WXXW motif in the TSR1 of ADAMTS13 is important for its secretion and proteolytic activity.
    Ling J; Su J; Ma Z; Ruan C
    Thromb Res; 2013 Jun; 131(6):529-34. PubMed ID: 23683325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levels of von Willebrand factor antigen and von Willebrand factor cleaving protease (ADAMTS13) activity predict clinical events in chronic heart failure.
    Gombos T; Makó V; Cervenak L; Papassotiriou J; Kunde J; Hársfalvi J; Förhécz Z; Pozsonyi Z; Borgulya G; Jánoskuti L; Prohászka Z
    Thromb Haemost; 2009 Sep; 102(3):573-80. PubMed ID: 19718479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of von Willebrand factor and ADAMTS13 in the no-reflow phenomenon: after primary percutaneous coronary intervention.
    Zhao B; Li J; Luo X; Zhou Q; Chen H; Shi H
    Tex Heart Inst J; 2011; 38(5):516-22. PubMed ID: 22163125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of plasma von Willebrand factor and its cleaving protease ADAMTS13 in patients with atrial fibrillation.
    Freynhofer MK; Gruber SC; Bruno V; Höchtl T; Farhan S; Zaller V; Wojta J; Huber K
    Int J Cardiol; 2013 Sep; 168(1):317-25. PubMed ID: 23041092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression of vWF73 and VWF114 fragments of von Willebrand factor A2 domain and their utilization in detecting ADAMTS13 activity].
    Zhang JY; Ma ZN; Dong NZ; Hu LP; Su J; Wang ZY; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2011 May; 32(5):337-41. PubMed ID: 21729605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ADAMTS13 and von Willebrand factor concentrations in patients with diabetes mellitus.
    Skeppholm M; Kallner A; Kalani M; Jörneskog G; Blombäck M; Wallén HN
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):619-26. PubMed ID: 19809308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in von Willebrand factor and ADAMTS-13 in patients following arthroplasty.
    Liu L; Ling J; Ma Z; Yuan Q; Pan J; Yang H
    Mol Med Rep; 2015 Apr; 11(4):3015-20. PubMed ID: 25482054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of FRETS-VWF73 to full-length VWF as a substrate for ADAMTS13 activity measurement in human plasma samples.
    Mahdian R; Rayes J; Girma JP; Houllier A; Obert B; Meyer D; Veyradier A
    Thromb Haemost; 2006 Jun; 95(6):1049-51. PubMed ID: 16732393
    [No Abstract]   [Full Text] [Related]  

  • 31. Expression of ADAMTS13 in Normal and Abnormal Placentae and Its Potential Role in Angiogenesis and Placenta Development.
    Xiao J; Feng Y; Li X; Li W; Fan L; Liu J; Zeng X; Chen K; Chen X; Zhou X; Zheng XL; Chen S
    Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1748-1756. PubMed ID: 28751574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Changes of ADAMTS13 activity and vWF antigen level in patients with acute myelogenous leukemia and their significance].
    Zhang WJ; Han Y; Ma ZN; Wang Q; Tang YQ; Wang J; Su J; Sun AN; Wang ZY; Ruan CG; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1503-7. PubMed ID: 25543464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FRETS-VWF73 rather than CBA assay reflects ADAMTS13 proteolytic activity in acquired thrombotic thrombocytopenic purpura patients.
    Mancini I; Valsecchi C; Lotta LA; Deforche L; Pontiggia S; Bajetta M; Palla R; Vanhoorelbeke K; Peyvandi F
    Thromb Haemost; 2014 Aug; 112(2):297-303. PubMed ID: 24740645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential role of enhanced cytokinemia and plasma inhibitor on the decreased activity of plasma ADAMTS13 in patients with alcoholic hepatitis: relationship to endotoxemia.
    Ishikawa M; Uemura M; Matsuyama T; Matsumoto M; Ishizashi H; Kato S; Morioka C; Fujimoto M; Kojima H; Yoshiji H; Tsujimoto T; Takimura C; Fujimura Y; Fukui H
    Alcohol Clin Exp Res; 2010 Feb; 34 Suppl 1():S25-33. PubMed ID: 19094193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left atrial blood stasis and Von Willebrand factor-ADAMTS13 homeostasis in atrial fibrillation.
    Ammash N; Konik EA; McBane RD; Chen D; Tange JI; Grill DE; Herges RM; McLeod TG; Friedman PA; Wysokinski WE
    Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2760-6. PubMed ID: 21852562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High levels of von Willebrand factor and low levels of its cleaving protease, ADAMTS13, are associated with stroke in young HIV-infected patients.
    Allie S; Stanley A; Bryer A; Meiring M; Combrinck MI
    Int J Stroke; 2015 Dec; 10(8):1294-6. PubMed ID: 26121272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Development of a novel ADAMTS13 activity assay for diagnosis of TMA and criteria for judgment of platelet transfusion].
    Hiura H
    Rinsho Byori; 2007 Jan; 55(1):69-75. PubMed ID: 17319494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ADAMTS13 and von Willebrand factor and the risk of myocardial infarction in men.
    Chion CK; Doggen CJ; Crawley JT; Lane DA; Rosendaal FR
    Blood; 2007 Mar; 109(5):1998-2000. PubMed ID: 17053057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations between the von Willebrand Factor-ADAMTS13 Axis, Complement Activation, and COVID-19 Severity and Mortality.
    Sinkovits G; Réti M; Müller V; Iványi Z; Gál J; Gopcsa L; Reményi P; Szathmáry B; Lakatos B; Szlávik J; Bobek I; Prohászka ZZ; Förhécz Z; Mező B; Csuka D; Hurler L; Kajdácsi E; Cervenak L; Kiszel P; Masszi T; Vályi-Nagy I; Prohászka Z
    Thromb Haemost; 2022 Feb; 122(2):240-256. PubMed ID: 35062036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in plasma von Willebrand factor and ADAMTS13 levels associated with left atrial remodeling in atrial fibrillation.
    Uemura T; Kaikita K; Yamabe H; Soejima K; Matsukawa M; Fuchigami S; Tanaka Y; Morihisa K; Enomoto K; Sumida H; Sugiyama S; Ogawa H
    Thromb Res; 2009 May; 124(1):28-32. PubMed ID: 18996572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.